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the management of civilian vascular injuries
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Kay R. Goshima, MD,c Peter Rhee, MD,d and Joseph L. Mills Sr, MD,c Tucson, Ariz, and Houston, Tex
Objective: The rapid evolution of endovascular surgery has greatly expanded management options for a wide variety of
vascular diseases. Endovascular therapy provides a less invasive alternative to open surgery for critically ill patients who
have sustained arterial injuries. The purpose of this study was to evaluate recent trends in the management of arterial
injuries in the United States with speciﬁc reference to the use of endovascular strategies and to examine the outcomes of
endovascular vs open therapy for the treatment of civilian arterial traumatic injuries.
Methods: A 9-year analysis of the National Trauma Data Bank was performed to identify all patients who sustained arterial
injuries. Demographics, clinical data, interventions, and outcomes were extracted. Propensity scores were used to match
endovascular patients to those undergoing open operation. Patient outcomes were compared according to treatment
approach.
Results: A total of 23,105 patients were available for analysis. Overall, there was a signiﬁcant increase in the use of endo-
vascular procedures during 9 years (from0.3% in 2002 to 9.0% in 2010;P< .001), particularly amongblunt trauma patients
(from 0.4% in 2002 to 13.2% in 2010; P < .001). This increase was noteworthy and dramatic for injuries of the internal iliac
artery (from 8.0% in 2002 to 40.3% in 2010; P < .001), thoracic aorta (from 0.5% in 2002 to 21.9% in 2010; P < .001), and
common/external iliac arteries (from 0.4% in 2002 to 20.4% in 2010; P < .001). A signiﬁcant decrease was noted for open
procedures (49.1% in 2002 to 45.6%; P < .001), especially for blunt trauma (42.9% in 2002 to 35.8% in 2010; P < .001).
There was a stepwise increase in the proportion of patients managed by endovascular therapy as the Injury Severity Score
increased (highest in the spectrum Injury Severity Score 31-50). When outcomes were compared betweenmatched patients
who underwent endovascular and open procedures, patients who underwent endovascular procedures had signiﬁcantly
lower in-hospital mortality (12.9% vs 22.4%; odds ratio, 0.5; 95% conﬁdence interval, 0.4-0.6; P < .001). Endovascular
patients also had decreased rates of sepsis (7.5% vs 5.4%; odds ratio, 0.7; 95% conﬁdence interval, 0.5-0.9; P[ .025).
Conclusions: The use of endovascular therapy in the United States has increased dramatically during the last decade, in
particular among severely injured blunt trauma patients. Endovascular therapy was associated with improved in-hospital
mortality and lower rates of sepsis. (J Vasc Surg 2014;60:1297-307.)From balloon tamponade to fenestrated grafts, the
evolving ﬁeld of endovascular surgery has greatly expanded
management options for a wide variety of vascular diseases.
Ongoing device developments and reﬁnements, along with
better understanding of the natural history of many
vascular pathologic processes, have allowed the trial and
implementation of endovascular procedures to virtually all
vascular processes. In many instances, this new technology
provides a safe, minimally invasive, and superior in perfor-
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://dx.doi.org/10.1016/j.jvs.2014.05.028Despite advancements in cross-sectional imaging and
transfusion strategies, uncontrolled hemorrhage remains
the leading cause of death among critically ill trauma pa-
tients.4-6 Many of those will expire as a result of exsangui-
nation from a vascular injury before bleeding control can
be achieved. Traditionally, the management of these in-
juries requires open exploration in which adequate expo-
sure is pivotal to allow bleeding control. Success with this
approach is, however, often affected by our ability to obtain
proximal and distal vascular control, by the degree of
anatomic distortion caused by hematoma or soft tissue
injury, and by the proximity to neurovascular bundles
and bone structures.
Endovascular therapy provides an elegant alternative to
open surgery with the potential advantage of allowing con-
trol of bleeding without the need for vessel exposure, miti-
gating the risk of collateral damage to adjacent structures.
As trauma centers evolve to become equipped to offer
endovascular options on an emergent basis to trauma pa-
tients, several studies have emerged in the literature docu-
menting an increase in use of endovascular therapy for a
wide variety of arterial injuries, including carotid, thoracic
and abdominal aorta, subclavian and axillary arteries, and
iliac and lower limb systems.7-17 Although uniformly posi-
tive, this experience remains conﬁned to small retrospective
studies.1297
Table I. Patient characteristics
Unmatched Matched
Endovascular
(n ¼ 2570), No. (%)
Open
(n ¼ 19,693), No. (%) P
Endovascular
(n ¼ 1388), No. (%)
Open
(n ¼ 1388), No. (%) P
Demographics
Age, years 42.4 6 19.8;
[40], (1-93)
33.6 6 15.9;
[29], (1-107)
<.001a 41.6 6 19.4;
[39], (1-93)
41.4 6 19.5;
[38], (1-107)
.769
Age $55 years 712 (28.0) 2222 (11.4) <.001a 365 (26.3) 361 (26.0) .863
Age $75 years 216 (8.5) 478 (2.5) <.001a 103 (7.4) 108 (7.8) .720
Male 1867 (72.8) 15,636 (79.4) <.001a 1047 (75.4) 1060 (76.4) .594
White 1705 (66.3) 9017 (45.8) <.001a 868 (62.5) 869 (62.6) .969
Hispanic 36 (1.4) 1128 (5.7) <.00a 36 (2.6) 45 (3.2) .367
African American 413 (16.1) 5786 (29.4) <.001a 254 (18.3) 257 (18.5) .883
Uninsured 358 (13.9) 4749 (24.1) <.001a 233 (16.8) 241 (17.4) .687
Medicaid/Medicare 578 (22.5) 4003 (20.3) <.001a 305 (22.0) 299 (21.5) .783
Facility description
University 1571(61.1) 11,448 (58.1) <.001a 882 (63.5) 886 (63.8) .906
Community 649 (25.3) 5049 (25.6) .479 398 (28.7) 414 (29.8) .531
Nonteaching 350 (13.6) 3196 (16.3) <.001a 97 (7.0) 88 (6.3) .548
ACS level I 1805 (70.2) 11,875 (60.3) <.001a 1017 (73.3) 1001 (72.1) .522
ACS level II 451 (17.5) 9366 (22.6) <.001a 340 (24.5) 320 (23.1) .397
Adult beds 502.4 6 220;
[457], (50-1188)
475.8 6 258;
[434], (50-1188)
<.001a 499.1 6 220;
[457], (50-1188)
500.4 6 255;
[447], (50-1188)
.890
Clinical data
Penetrating 312 (12.1) 10,315 (52.4) <.001a 215 (15.5) 242 (17.4) .267
SW 84 (3.3) 3448 (17.5) <.001a 65 (4.7) 73 (5.3) .485
GSW 228 (8.9) 6875 (34.9) <.001a 150 (10.8) 169 (12.2) .258
SBP on admission 116.7 6 33.9;
[118], (0-233)
112.2 6 37.3;
[116], (0-254)
<.001a 116.7 6 33.1;
[118], (0-227)
115.0 6 38.6;
[118], (0-244)
.213
SBP on
admission <90 mm
Hg
356 (18.0) 3355 (21.1) .001a 255 (18.8) 290 (20.9) .280
GCS score on
admission #8
475 (27.6) 3175 (21.3) <.001a 297 (26.8) 310 (27.3) .767
þETOH 521 (20.3) 4501 (22.9) .003a 285 (20.5) 288 (20.7) .888
þDrug screen 438 (17.0) 3158 (16.0) .192 238 (17.1) 223 (16.1) .444
COPD 108 (4.2) 478 (2.4) <.001a 53 (3.8) 51 (3.7) .842
DM 159 (6.2) 570 (2.9) <.001a 82 (5.9) 76 (5.5) .623
HTN 448 (17.4) 1481 (7.5) <.001a 218 (15.7) 204 (14.7) .459
CAD 67 (2.6) 570 (2.9) .354 42 (3.0) 47 (3.4) .590
CHF 32 (1.2) 86 (0.4) <.001a 18 (1.3) 14 (1.0) .477
CKD on dialysis 11 (0.4) 25 (0.1) .579 4 (0.3) 4 (0.3) 1.000
Associated injuries
ISS 27.8 6 13.3;
[26], (1-75)
16.9 6 13.8;
[12], (1-75)
<.001a 27.0 6 13.8;
[26], (1-75)
27.1 6 15.5;
[26], (1-75)
.895
ISS $16 1929 (87.2) 8170 (44.5) <.001a 1161 (83.7) 1136 (81.8) .209
ISS $25 1252 (56.6) 4602 (25.1) <.001a 754 (54.4) 774 (55.8) .458
Traumatic brain
injury
1142 (44.4) 3690 (18.7) <.001a 562 (40.5) 552 (39.8) .699
SDH, SAH, EDH,
DAI, IPH
472 (18.4) 1283 (6.5) <.001a 204 (14.7) 205 (14.8) .957
Hemothorax or
pneumothorax
1025 (39.9) 3612 (18.3) <.001a 534 (38.5) 532 (38.3) .938
Solid organ injury 1074 (41.8) 3719 (18.9) <.001a 558 (40.2) 548 (39.5) .698
Hollow viscus injury 336 (13.1) 3571 (18.1) <.001a 182 (13.1) 196 (14.1) .438
Upper extremity
fracture/
dislocation
803 (31.2) 4071 (20.7) <.001a 411 (29.6) 408 (29.4) .901
Lower extremity
fracture/
dislocation
866 (33.7) 5489 (27.9) <.001a 485 (34.9) 472 (34.0) .604
Location of arterial
injury
Head/neck 258 (10.0) 1455 (7.4) <.001a 125 (9.0) 141 (10.2) .302
Thorax 1230 (47.9) 3138 (15.9) <.001a 638 (46.0) 617 (44.5) .423
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Table I. Continued.
Unmatched Matched
Endovascular
(n ¼ 2570), No. (%)
Open
(n ¼ 19,693), No. (%) P
Endovascular
(n ¼ 1388), No. (%)
Open
(n ¼ 1388), No. (%) P
Abdomen/pelvis 1040 (40.5) 5110 (25.9) <.001a 543 (39.1) 573 (41.3) .246
Upper extremity 63 (2.5) 4508 (22.9) <.001a 47 (3.4) 47 (3.4) 1.000
Lower extremity 189 (7.4) 6625 (33.6) <.001a 128 (9.2) 129 (9.3) .948
ACS, American College of Surgeons; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive
pulmonary disease; DAI, diffuse axonal injury; DM, diabetes mellitus; EDH, epidural hematoma; ETOH, ethanol; GCS, Glasgow Coma Scale; GSW, gunshot
wound; HTN, hypertension; IPH, intraparenchymal hemorrhage; ISS, Injury Severity Score; SAH, subarachnoid hemorrhage; SBP, systolic blood pressure;
SD, standard deviation; SDH, subdural hematoma; SW, stab wound.
Patients were matched for the variables that were signiﬁcantly different (a) and for arterial injuries sustained. For the unmatched cohorts, the P values for
categorical variables were derived from c2 and Fisher exact tests; P values for continuous variables were derived from unpaired Student t-test and Mann-
Whitney tests. For the matched cohorts, the P values for categorical variables were derived from McNemar c2 test; P values for continuous variables were
derived from paired Student t-test. Continuous variables were reported as mean 6 standard deviation; [median], (range).
aP values are signiﬁcantly different (P < .05).
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recent trends in management of arterial injuries in the
United States with speciﬁc reference to the use of endovas-
cular strategies and (2) to examine the outcomes of endo-
vascular vs open therapy for the treatment of arterial
injuries among civilian trauma patients. Our hypothesis
was that (1) endovascular arterial injury control or repair
would be increasing in the United States for the manage-
ment of both blunt and penetrating arterial injuries, in
particular among severely injured patients, and that (2)
endovascular therapy would be associated with lower rates
of in-hospital complications and improved survival.
METHODS
This is an analysis of the National Trauma Data Bank
(NTDB) of the American College of Surgeons from the
years 2002 to 2010 including a total of 3,894,335 medical
records of injured patients admitted to 1205 trauma cen-
ters across the United States. All data provided by the
NTDB are de-identiﬁed and subjected to quality screening
for consistency and validity. Use of NTDB data is in strict
compliance with the Health Insurance Portability and
Accountability Act of 1996.
Patients who sustained vascular injuries were identiﬁed
by the International Classiﬁcation of Diseases, Ninth Revi-
sion, Clinical Modiﬁcation (ICD-9-CM) codes D900-904.
From that cohort, those who sustained arterial injuries
were extracted (Supplementary Table, online only). For
the purpose of the analysis, a diagnosis description contain-
ing the term “unspeciﬁed” was excluded. Those with a
diagnosis description in which arterial and venous injuries
could not be differentiated, such as D903.3, “ulnar blood
vessels,” or 904.6, “deep plantar blood vessels,” were
also excluded from analysis. We included patients with
associated diagnosis codes for arterial injuries.
Data abstracted included age, gender, ethnicity, insur-
ance status, facility description, mechanism of injury, sys-
tolic blood pressure (SBP), Glasgow Coma Scale score,
ethanol and drug screen on admission, comorbidities(chronic obstructive pulmonary disease, diabetes mellitus,
hypertension, coronary artery disease, congestive heart fail-
ure, and chronic kidney disease on dialysis), Injury Severity
Score (ISS), associated injuries sustained, operative proce-
dures, and outcomes. Operative data including type and
number of procedures as well as time from admission to
procedure and total operative time were also extracted.
The primary outcome measure was in-hospital mortality.
Secondary outcomes included in-hospital complications
(acute respiratory distress syndrome, pneumonia, sepsis,
acute renal failure, surgical site infections, and compart-
ment syndrome), need for limb amputation, ventilation
days, hospital length of stay, intensive care unit length of
stay, and patient disposition (home vs skilled nursing facil-
ity vs rehabilitation vs other [transferred, jail, left against
medical advice]).
We identiﬁed patients who underwent endovascular
management on the basis of ICD procedure codes 00.55,
00.61-5, 39.50, 39.71-4, 39.79, and 39.90 and those
who underwent open procedures on the basis of ICD pro-
cedure codes 38.00-38, 38.40-48, 38.60-68, and 39.00-
59. We identiﬁed patients who sustained arterial injuries
without associated ICD procedure codes to capture pa-
tients who underwent nonoperative management. The
number of patients undergoing endovascular, open, and
nonoperative managements was determined for each year
and for the entire time period. Surgical patients were
assessed for the occurrence of outcomes related to their
admission by type of operation (endovascular vs open).
Statistical analysis. Patients undergoing endovascular
or open procedures were compared for differences in clin-
ical characteristics and location of arterial injury by bivariate
analysis. The c2 and Fisher exact tests were used to
compare proportions, and unpaired Student t-test and
Mann-Whitney U tests were performed to compare means.
Because the number of confounders was large in com-
parison to the number of events, patients undergoing
endovascular therapy were matched in a 1:1 ratio to pa-
tients who underwent open procedures by propensity
Table II. Distribution of arterial injuries between study groups
Unmatched Matched
Endovascular
(n ¼ 2570),
No. (%)
Open
(n ¼ 19,693),
No. (%) P
Endovascular
(n ¼ 1388),
No. (%)
Open
(n ¼ 1388),
No. (%) P
Arterial injuries
Number, mean 6 SD; [median],
(range)
1.1 6 0.3;
[1], (1-4)
1.1 6 0.3;
[1], (1-4)
.157 1.1 6 0.3;
[1], (1-3)
1.1 6 0.3;
[1], (1-3)
.771
Head/neck
Internal carotid artery 153 (6.0) 493 (2.5) <.001a 77 (5.5) 79 (5.7) .869
Common/external carotid arteries 100 (3.9) 918 (4.7) .079 52 (3.7) 65 (4.7) .219
Thorax
Thoracic aorta 1158 (45.1) 2153 (10.9) <.001a 592 (42.7) 565 (40.7) .299
Subclavian/innominate arteries 72 (2.8) 674 (3.4) .100 46 (3.3) 44 (3.2) .830
Pulmonary artery 10 (0.4) 263 (1.3) <.001a 8 (0.6) 10 (0.7) .636
Abdomen/pelvis
Abdominal aorta 101 (3.9) 736 (3.7) .629 49 (3.5) 56 (4.0) .486
Celiac/mesenteric arteries 305 (11.9) 2232 (11.3) .423 168 (12.1) 187 (13.5) .280
Renal artery 100 (3.9) 472 (2.4) <.001a 57 (4.1) 63 (4.5) .576
Internal iliac artery 66 (2.6) 119 (0.6) <.001a 37 (2.7) 37 (2.7) 1.000
Common/external iliac arteries 504 (19.6) 1730 (8.8) <.001a 252 (18.2) 267 (19.2) .465
Upper extremity
Axillary artery 27 (1.1) 807 (4.1) <.001a 20 (1.4) 21 (1.5) .875
Brachial artery 36 (1.4) 3736 (19.0) <.001a 27 (1.9) 20 (1.4) .234
Lower extremity
Common femoral artery 69 (2.7) 1185 (6.0) <.001a 41 (3.0) 40 (2.9) .910
Superﬁcial femoral artery 74 (2.9) 2119 (10.8) <.001a 48 (3.5) 48 (3.5) 1.000
Popliteal artery 41 (1.6) 2462 (12.5) <.001a 31 (2.2) 26 (1.9) .503
Anterior tibial artery 13 (0.5) 563 (2.9) <.001a 9 (0.6) 6 (0.4) .437
Posterior tibial artery 8 (0.3) 787 (4.0) <.001a 7 (0.5) 11 (0.8) .344
Venous injuries
$1 98 (3.8) 4075 (20.7) <.001a 68 (4.9) 68 (4.9) 1.000
SD, Standard deviation.
Patients were matched for the variables that were signiﬁcantly different (a) and for patient characteristics. For the unmatched cohorts, the P values for cat-
egorical variables were derived from c2 and Fisher exact tests; P values for continuous variables were derived from unpaired Student t-test and Mann-Whitney
tests. For the matched cohorts, the P values for categorical variables were derived from McNemar c2 test; P values for continuous variables were derived from
paired Student t-test.
aP values are signiﬁcantly different (P < .05).
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variables that differed signiﬁcantly (at the P < .05 level) be-
tween the two cohorts (Tables I and II).
Propensity scores (predicting the probability of under-
going endovascular therapy) were calculated with binary
logistic regression. Each patient undergoing an endovascu-
lar procedure was matched to a patient who underwent an
open procedure within a 0.04 caliper of propensity without
replacement. The caliper was equal to one quarter of a
standard deviation of the logit of the propensity (caliper
was 0.15/4z0.04).19 Patients for whom no suitable
match could be found were excluded.
The two groups were compared for differences in clin-
ical characteristics and location of injury. McNemar c2 test
was used to compare proportions and paired Student t-test
to compare means.
Primary and secondary outcomes between matched co-
horts were compared by McNemar c2 test for proportions
and Wilcoxon test for matched sample for means. In addi-
tion, a Kaplan-Meier time to event analysis was used to
evaluate the association between the type of procedure(endovascular vs open) and in-hospital survival. Log-rank
test was used for comparison of survival curves. To deter-
mine whether endovascular therapy had any independent
association with in-hospital mortality, a stepwise logistic
regression analysis was performed including all covariates
potentially associated with this outcome. These variables
were examined for their effect by bivariate analysis. To
identify independent predictors for mortality, factors that
on bivariate analysis were signiﬁcant at P < .2 were entered
in a stepwise logistic regression analysis.
Values are reported as means 6 standard deviation, as
median (range) for continuous variables, and as percentage
for categorical variables. All analyses were performed with
the Statistical Package for Social Sciences (SPSS Mac),
version 18.0 (SPSS Inc, Chicago, Ill).
RESULTS
During the 9-year study period, 85,292 (2.2%) of the
3,894,335 NTDB patients sustained a vascular injury. After
exclusion of 41,328 patients (48.4%) with “unspeciﬁed,”
“undifferentiated,” or isolated venous injuries, 43,964
Fig 1. Study outline. A total of 842 patients (1.9%) who sustained arterial injuries underwent hybrid (open and
endovascular) procedures. NOM, Nonoperative management. NTDB, National Trauma Data Bank.
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patients (5.8%) underwent endovascular procedures,
20,535 patients (46.7%) underwent open procedures, and
21,701 patients (49.4%) underwent nonoperative manage-
ment (Fig 1).
During the study period, the mean number of trauma
admissions/year was 432,703 6 215,304. The annual
management trends are depicted in Fig 2. Overall, there
was a signiﬁcant increase in the use of endovascular proce-
dures during 9 years (from 0.3% in 2002 to 9.0% in 2010;
P < .001). Conversely, a signiﬁcant decrease was noted for
open and nonoperative managements (P < .001; Fig 2).
When these trends were analyzed according to injury
mechanism, for blunt trauma, endovascular procedures
increased from 0.4% in 2002 to 13.2% in 2010 (P <
.001). There was a signiﬁcant decrease in open procedures
among blunt trauma patients (42.9% in 2002 to 35.8% in
2010; P < .001). No difference was noted for nonoperative
management (P ¼ .056). For penetrating trauma, there
was a statistically signiﬁcant but not clinically signiﬁcant in-
crease in endovascular procedures (from 0.2% in 2002
to 2.3% in 2010; P < .001). Nonoperative management
decreased during the study period (P < .001), and no
change was noted for open procedures (P ¼ .089; Fig 3).
Mortality for arterial injuries during the study period
decreased signiﬁcantly (from 28.1% in 2002 to 13.1% in
2010; P < .001; Fig 2). This was true for both blunt and
penetrating trauma (Fig 3).
When the speciﬁc types of injury were analyzed, a
growth in endovascular use was demonstrated for all arte-
rial injuries, in particular for the internal iliac artery (from
8.0% in 2002 to 40.3% in 2010; P < .001), thoracic aorta
(from 0.5% in 2002 to 21.9% in 2010; P < .001), and com-
mon/external iliac arteries (from 0.4% in 2002 to 20.4% in
2010; P < .001; Fig 4).When management trends were analyzed according to
ISS, there was a stepwise increase in the proportion of pa-
tients managed endovascularly as the ISS increased (highest
in the spectrum ISS 31-50). A stepwise decrease in open
procedures was seen with increasing ISS (lowest on ISS
51-75). Nonoperative management increased in a stepwise
fashion with increasing ISS (Fig 5).
Patient characteristics for the endovascular and open
groups before and after matching are described in Table I.
There were 1388 matched pairs. The average age of the
matched patients was 41.5 6 19.4 years; 74.8% were male
and 16.5% sustained penetrating trauma; 72.3% were
admitted to level I trauma centers and 63.7% to university-
based hospitals. At admission, 19.6% of the patients were hy-
potensive (SBP <90 mm Hg), 21.8% had a Glasgow Coma
Scale score #8, and 82.7% had an ISS $16 (Table I).
When body location of arterial injury was analyzed, 45.2%
had thoracic arterial injuries, 40.2% had abdominal/pelvic
injuries, and 9.3% had lower extremity injuries (Table I).
Table II depicts the distribution of arterial injuries be-
tween the study groups. Among matched patients, the
three most common types of arterial injuries were thoracic
aorta (41.7%), common/external iliac arteries (18.7%), and
celiac/mesenteric arteries (12.8%). The rate of associated
venous injury in the matched cohort was 4.9% (Table II).
Among matched patients, the mean time from admis-
sion to procedure was 10.6 6 33.7 hours, and the mean
duration of the procedure was 1.4 6 13.7 hours. Among
matched patients who underwent open procedures,
37.5% underwent primary repair, 39.1% interposition graft,
16.6% ligation, and 6.8% shunting. No hybrid procedures
(endovascular and open) were performed in the matched
cohort. When the rate of associated procedures was analyzed
among matched patients, the endovascular group was signif-
icantly less likely to undergo thoracotomy (2.3% vs 9.4%;
Fig 2. Management trends throughout the study period. There was a signiﬁcant increase in endovascular management
during 9 years (P < .001). A signiﬁcant decrease was noted for the open and nonoperative management (NOM) groups
(P < .001). Mortality signiﬁcantly decreased during the study period (P < .001). n, Number of patients per study year.
*Standard error exceeds 10%.
Fig 3. Management trends throughout the study period according to injury mechanism. For blunt trauma, there was a
signiﬁcant increase in endovascular management and a decrease in open procedures during 9 years (P < .001). No
difference was noted in the nonoperative management (NOM) group (P ¼ .056). Mortality for blunt trauma decreased
signiﬁcantly during the study period (P < .001). For penetrating trauma, there was a statistically signiﬁcant but not
clinically relevant increase in endovascular procedures (P < .001). Nonoperative management decreased during the
study period (P < .001), and no signiﬁcant change was noted for the open group (P ¼ .089). Mortality for penetrating
trauma decreased signiﬁcantly during the study period (P < .001). n, Number of patients per study year. *Standard
error exceeds 10%.
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tube thoracostomy (30.6% vs 35.5%; P ¼ .006).
When outcomes were compared between matched pa-
tients who underwent endovascular and open procedures,
patients who underwent endovascular procedures had
signiﬁcantly lower in-hospital mortality (12.9% vs 22.4%;
odds ratio [OR], 0.5; 95% conﬁdence interval [CI], 0.4-
0.6; P < .001). Endovascular patients also had a trend to-
ward lower complications, in particular sepsis (7.5% vs
5.4%; OR, 0.7; 95% CI, 0.5-0.9; P ¼ .025) and surgical
site infections (4.9% vs 6.6%; OR, 0.7; 95% CI, 0.5-1.0;
P ¼ .060). Similarly, there was a trend toward lower rates
of major amputation in the endovascular group, inparticular above-knee amputations (1.1% vs 1.9%; OR,
0.5; 95% CI, 0.3-1.1; P ¼ .083; Table III).
The endovascular group required mechanical ventila-
tion less frequently (57.6% vs 62.3%; P ¼ .013). There
were no signiﬁcant differences with regard to intensive
care unit length of stay (11.3 6 12.8 days vs 11.6 6
12.0 days; P ¼ .578) and hospital length of stay (18.8 6
19.1 days vs 18.2 6 19.3 days; P ¼ .408). There was a
trend toward lower hospital charges in the endovascular
group (178,400 6 240,000 vs 233,900 6 387,000;
P ¼ .130). Patients requiring endovascular therapy were
more likely to be discharged home (43.6% vs 33.9%; OR,
1.5; 95% CI, 1.3-1.8; P < .001; Table III).
Fig 4. Growth in endovascular procedures during the study period according to the type of arterial injury. Statistically
signiﬁcant growth was achieved for all injuries (P < .001).
Fig 5. Management according to Injury Severity Score (ISS). n, Number of patients; NOM, nonoperative
management.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 5 Branco et al 1303Kaplan-Meier time to event analysis revealed early
reduction of in-hospital mortality-free curves for endovas-
cular relative to open therapy (log-rank, P < .001;
Fig 6). A stepwise logistic regression analysis identiﬁed
endovascular therapy as an independent variable associated
with improved in-hospital mortality (adjusted OR, 0.4;
95% CI, 0.2-0.8; P ¼ .002). Other factors, such as age,
admission SBP <90 mm Hg, ISS $ 16, and traumatic
brain injury, were also found to be independent risk factors
for in-hospital death.
DISCUSSION
This study is the largest examination to date evaluating
the role of endovascular therapy in the management of
civilian arterial injuries. With two speciﬁc objectives
designed to address national trends and outcomes of endo-
vascular repair, we used the NTDB to screen more than 3.8
million patients for enrollment in this study. During a 9-yearstudy period, a total of 43,964 patients (1.1%) who sus-
tained arterial injuries were included in this analysis.
Arterial injuries, including occlusion, dissection, pseu-
doaneurysm, and arteriovenous ﬁstulas, have traditionally
been managed by open surgical repair. These repairs can
often be challenging, depending on urgency, degree of
associated injuries, anatomic distortion around the lesion,
excessive bleeding in the ﬁeld of operation, relationship
to neurovascular structures and bones, and degree of
contamination.1 In this situation, the use of endovascular
therapy offers many potential advantages over open opera-
tion. Although recently challenged by the increasing reso-
lution of computed tomography scans, angiography has
always been an integral component in the diagnosis and
evaluation of these lesions. Giving the surgeon the ability
also to treat these injuries away from the vicinity of the
injury may make remote access more advantageous. In in-
stances in which complete treatment of the vascular injury
Table III. Outcomes between patient groups
Endovascular (n ¼ 1388),
mean 6 SD
Open (n ¼ 1388),
mean 6 SD MD (95% CI) P
Hospital charges 178,4000 6 240,000 233,900 6 387,000 55,500 (16,000 to 127,000) .130
Ventilation days 10.5 6 13.4 9.9 6 11.5 0.6 (2.0 to 1.3) .190
ICU LOS 11.3 6 12.8 11.6 6 12.0 0.3 (0.7 to 1.2) .578
Hospital LOS 18.8 6 19.1 18.2 6 19.3 0.6 (2.0 to 0.9) .408
Endovascular
(n ¼ 1388), No. (%)
Open (n ¼ 1388),
No. (%) OR (95% CI) P
Ventilated 800 (57.6) 865 (62.3) 0.8 (0.7-0.9) .013a
ARDS 52 (3.7) 58 (4.2) 0.9 (0.6-1.3) .559
Pneumonia 222 (16.0) 247 (17.8) 0.9 (0.7-1.1) .205
Sepsis 75 (5.4) 104 (7.5) 0.7 (0.5-0.9) .025a
Acute renal failure 87 (6.3) 93 (6.7) 0.9 (0.7-1.2) .644
Surgical site infection 68 (4.9) 91 (6.6) 0.7 (0.5-1.0) .060
Compartment syndrome 52 (3.7) 62 (4.5) 0.8 (0.6-1.2) .339
Upper extremity amputation 7 (0.5) 11 (0.8) 0.6 (0.3-1.6) .344
Above-knee amputation 15 (1.1) 26 (1.9) 0.5 (0.3-1.1) .083
Below-knee amputation 7 (0.5) 14 (1.0) 0.5 (0.2-1.2) .125
Discharge to rehabilitation 429 (30.9) 438 (31.6) 0.9 (0.8-1.1) .712
Discharge to SNF 117 (8.4) 118 (8.5) 0.9 (0.8-1.3) .946
Discharge home 605 (43.6) 471 (33.9) 1.5 (1.3-1.8) <.001a
Otherb 58 (4.2) 52 (3.7) 1.1 (0.8-1.6) .559
Mortality 179 (12.9) 311 (22.4) 0.5 (0.4-0.6) <.001a
ARDS, Acute respiratory distress syndrome; CI, conﬁdence interval; ICU, intensive care unit; LOS, length of stay; MD, mean difference; OR, odds ratio; SD,
standard deviation; SNF, skilled nursing facility.
The ORs, MDs, and P values were obtained after matching for patient characteristics and arterial injuries sustained. The P values for categorical variables were
derived from McNemar c2 test; P values for continuous variables were derived from Wilcoxon matched pair test.
aP values are signiﬁcantly different (P < .05).
bOther: left against medical advice, transferred, discharged to jail.
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occlusion may offer precious time until open surgical access
is achieved.20
All these advantages have made open surgery no longer
the only therapeutic option. Indeed, since the ﬁrst reports of
stent graft treatment for arterial injuries in 1991,21,22 trau-
matic vascular injuries have been increasingly treated with
endovascular repair.7-14 Two studies have documented
this increase in use of endovascular procedures in theUnited
States. In 2007, Reuben et al23 from Salt Lake City, Utah,
used an earlier version of the NTDB including the years
1997 to 2003 to capture all patients who sustained arterial
injuries. They identiﬁed 12,732 patients; of those, 2.2% of
patients (281) were managed endovascularly. They were
able to demonstrate a 27-fold increase in endovascular pro-
cedures, in particular stent placements. Four years later,
Avery et al24 presented a similar analysis at the American As-
sociation for the Surgery of Trauma annual meeting evalu-
ating the evolving role of endovascular techniques for
treatment of vascular injuries in adult trauma patients (age
>14 years) with thoracic aorta, subclavian, or carotid artery
injuries. During a 6-year study period, they demonstrated an
increase in endovascular procedures from less than 1% of all
vascular injuries to numbers approaching 15%.
With regard to national trends in endovascular repair
use, the present analysis demonstrated a dramatic increase
in use of endovascular therapy to treat arterial injuriesfrom 0.2% of all injuries in 2002 to 9.0% in 2010
(P < .001). Although statistically this increase occurred for
both blunt and penetrating trauma, clinically, this increase
was relevant for blunt trauma (0.4% in 2002 to 13.2% in
2010). This increase in use has been especially true for crit-
ically ill trauma patients severely injured (highest in the spec-
trum of ISS 16-30 and 31-50). Interestingly, these
procedures have been performed early in the management
of the injured patient and even in those patients who tradi-
tionally were not good candidates for endovascular manage-
ment, such as hypotensive patients. Overall, there were 9237
(21.0%) hypotensive (SBP<90mmHg) patients in the total
cohort of patients who sustained arterial injuries. Of those,
356 (3.9%) underwent endovascular treatment. Although
this seems a small number, this represents 14% of all endo-
vascular procedures performed in the present study. To
date, endovascular procedures have been advocated for
those with less burden of injury and who are more stable.
Trauma and acute care surgeons may feel more comfortable
allowing relatively stable patients to be transported to a spe-
cial procedures suite to accomplish treatment. As hybrid
operating rooms with imaging capability and endovascular
inventory are implemented across the country, severely ill
and even unstable patients can now be treated while
ongoing trauma evaluation and resuscitation occur.
Our second speciﬁc objective was to evaluate the
impact of the shift toward endovascular treatment on
Fig 6. Time to event analysis for mortality. HLOS, Hospital
length of stay. Survival curves with 95% conﬁdence intervals.
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aortic trauma. Since the publication by Kato et al25 report-
ing the ﬁrst trauma case treated with an endovascular stent
graft in 1997, the literature has been ﬁlled by retrospective
studies comparing the outcomes between open and
endovascular repairs.8-11,14 One important study has pro-
spectively demonstrated the beneﬁts associated with endo-
vascular procedures. In 2008, Demetriades et al26
conducted a multicenter study including 18 centers and
193 patients (68 open and 125 endovascular), demon-
strating signiﬁcantly lower mortality (7.2% vs 23.5%;
adjusted P ¼ .001) and fewer blood transfusions in favor
of endovascular repair; however, a 20% rate of device-
related complications in the endovascular group was also
demonstrated. This rate of device-related complications
has been much decreased in recent studies, including the
RESCUE trial, which was conducted to evaluate the Med-
tronic Valiant Captivia stent graft (Medtronic Vascular,
Santa Rosa, Calif), enrolling 50 patients who sustained
blunt thoracic aortic injuries at 20 sites in North America.27
In that study, no endoleaks were reported.27
The beneﬁts of endovascular therapy have also been
demonstrated in a retrospective fashion for a wide variety
of vascular injuries including the carotid artery, abdominal
aorta, subclavian and axillary system, and iliac and femoral
arteries.7,12,13,15,16 For axillosubclavian injuries, a recent
review of published experience by DuBose et al17 demon-
strated promising results with endovascular stenting. These
beneﬁts include the avoidance of intracavitary surgerye
associated complications, no need for aortic cross-
clamping or extracorporeal bypass, and lower transfusionrequirements. In our outcome analysis, patients who un-
derwent endovascular procedures tended to be more
severely injured, with higher rates of associated traumatic
brain injury and thoracic and abdominal trauma. As might
be expected, these patients also had higher rates of comor-
bidities. To mitigate the differences between groups, pro-
pensity scoring was used to allow a direct comparison
between similar groups differing only in their surgical man-
agement. Patients were matched for 63 distinct variables
including the types of arterial injury sustained. When out-
comes were analyzed, patients who underwent endovascu-
lar procedures had signiﬁcantly lower in-hospital mortality
and fewer complications, in particular sepsis.
As acute care surgery models are implemented across
North America, acute care surgery teams are faced with
an expanded scope of practice for which adequate prepara-
tion is required. In view of the evolving role of endovascu-
lar therapy for the management of traumatic vascular
injuries, the addition of vascular surgeons with advanced
endovascular skills to acute care surgery teams seems
logical.
Although our study has the largest sample size of any
endovascular study currently in the literature, there are
well-known limitations to analysis of large administrative
databases. The NTDB collects its data from those centers
willing to contribute to the database. Therefore, our vari-
able of interest, endovascular therapy, is limited to those
centers that are willing to report or are capable of reporting
data to the NTDB. This study is a retrospective analysis of
population-based data that were not collected to answerer
our two hypotheses regarding national trends and out-
comes of endovascular procedures. As with any national
database studies, the completeness and accuracy of the
data are not as robust as for data collected in prospective
studies; therefore, the possibility of inaccurate data exists.
This is exempliﬁed by the low rate of venous injury in
the present cohort, as these injuries are frequently under-
reported during open repair and rarely recognized in pa-
tients undergoing endovascular therapy. Similarly, the
extent of soft tissue injury was not available for analysis.
This is another important variable in deciding between
open and endovascular repair. Furthermore, data such as
patient transfusion requirements and laboratory results
were unavailable for analysis. In addition, we were limited
by ICD-9-CM procedure codes, which hindered us from
extracting the speciﬁc types of endovascular procedures
performed. This is a signiﬁcant limitation that should be
addressed in future studies evaluating the role of endovas-
cular therapy for vascular trauma. Similarly, injury anatomy
and grade were not available for analysis.
To assess whether the results favoring endovascular
therapy presented in this analysis were affected by temporal
relationships or survival bias, we reanalyzed our data
set excluding early deaths (within 24 hours of hospital
admission). In this second analysis, in-hospital mortality
for patients undergoing endovascular therapy remained
signiﬁcantly lower than mortality for those undergoing
open repair (8.9% vs 12.0%; P ¼ .011), demonstrating
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is not merely due to the use of open therapy when death is
imminent.
Whereas our large longitudinal analysis provides indis-
putable evidence of the expansion of endovascular therapy
in the management of arterial trauma, our outcome analysis
is limited by small numbers, and therefore propensity to
bias exists. Because patients undergoing open and endovas-
cular therapy were substantially different with regard to de-
mographics and clinical data, propensity scoring was used
to identify a comparable cohort. This methodology, how-
ever, resulted in exclusion of more than 90% of the original
study population as we were unable to match patients in
any other ratio than 1:1. Therefore, the endovascular out-
comes presented in this analysis may not be indicative of all
possible endovascular outcomes. Another important limita-
tion of this type of analysis is that even in a matched analysis
controlling for a large number of confounders like the pre-
sent one, it is still possible that unmeasured differences be-
tween the two management arms were not accounted for
during the matching process. This could explain, at least
in part, the discrepancy in outcomes favoring endovascular
therapy.
Finally, and perhaps most important, in this study, the
mortality rate for arterial injuries decreased over time,
whereas the rates of endovascular procedures increased. It
is difﬁcult to draw any direct causality on the basis of the
present analysis. The fact that mortality rates for pene-
trating trauma decreased over time while endovascular pro-
cedures did not increase in a clinically relevant manner
speaks toward other factors affecting the outcomes in the
present analysis. In other words, trauma care is constantly
evolving, and this may affect outcomes in the longitudinal
design of this study.
However, there are a number of strengths to analysis of
these types of databases: large patient population; ability to
measure trends over time; and accurate information on de-
mographics and outcomes of interest, such as mortality,
which is tracked diligently by reporting centers.
CONCLUSIONS
The use of endovascular therapy in the United States
has increased dramatically during the last decade, particu-
larly among severely injured blunt trauma patients. Endo-
vascular therapy was associated with improved in-hospital
mortality and lower rates of sepsis.
AUTHOR CONTRIBUTIONS
Conception and design: BB, JD, LZ, JM
Analysis and interpretation: BB, JD
Data collection: BB
Writing the article: BB, JD
Critical revision of the article: LZ, JH, KG, PR
Final approval of the article: BB, JD, JM
Statistical analysis: BB
Obtained funding: Not applicable
Overall responsibility: BBREFERENCES
1. McArthur CS, Marin ML. Endovascular therapy for the treatment of
arterial trauma. Mt Sinai J Med 2004;71:4-11.
2. Hershberger RC, Aulivola B, Murphy M, Luchette FA. Endovascular
grafts for treatment of traumatic injury to the aortic arch and great
vessels. J Trauma 2009;67:660-71.
3. Valentine RJ, Rhodes RS, Jones A, Biester TW. Members of the
Vascular Surgery Board of the American Board of Surgery. Evolving
patterns of vascular surgery care in the United States: a report from the
American Board of Surgery. J Am Coll Surg 2013;216:886-93.e1.
4. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early
coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.
5. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC,
et al. Increased mortality associated with the early coagulopathy of
trauma in combat casualties. J Trauma 2008;64:1459-63; discussion:
1463-5.
6. Teixeira PG, Inaba K, Hadjizacharia P, Brown C, Salim A, Rhee P,
et al. Preventable or potentially preventable mortality at a mature
trauma center. J Trauma 2007;63:1338-46; discussion: 1346-7.
7. Velmahos GC, Chahwan S, Hanks SE, Murray JA, Berne TV,
Asensio J, et al. Angiographic embolization of bilateral internal iliac
arteries to control life-threatening hemorrhage after blunt trauma to
the pelvis. Am Surg 2000;66:858-62.
8. Tehrani HY, Peterson BG, Katariya K, Morasch MD, Stevens R,
DiLuozzo G, et al. Endovascular repair of thoracic aortic tears. Ann
Thorac Surg 2006;82:873-7; discussion: 877-8.
9. Pratesi C, Dorigo W, Troisi N, Pratesi G, Santoro G, Stefano P, et al.
Acute traumatic rupture of the descending thoracic aorta: endovascular
treatment. Am J Surg 2006;192:291-5.
10. Piffaretti G, Benedetto F, Menegolo M, Antonello M, Tarallo A,
Grego F, et al. Outcomes of endovascular repair for blunt thoracic
aortic injury. J Vasc Surg 2013;58:1483-9.
11. Peterson BG, Matsumura JS, Morasch MD, West MA, Eskandari MK.
Percutaneous endovascular repair of blunt thoracic aortic transection.
J Trauma 2005;59:1062-5.
12. Johnson CA. Endovascular management of peripheral vascular trauma.
Semin Intervent Radiol 2010;27:38-43.
13. DuBose J, Recinos G, Teixeira PG, Inaba K, Demetriades D. Endo-
vascular stenting for the treatment of traumatic internal carotid injuries:
expanding experience. J Trauma 2008;65:1561-6.
14. Andrassy J, Weidenhagen R, Meimarakis G, Lauterjung L, Jauch KW,
Kopp R. Stent versus open surgery for acute and chronic traumatic
injury of the thoracic aorta: a single-center experience. J Trauma
2006;60:765-71; discussion: 771-2.
15. Shalhub S, Starnes BW, Tran NT, Hatsukami TS, Lundgren RS,
Davis CW, et al. Blunt abdominal aortic injury. J Vasc Surg 2012;55:
1277-85.
16. Danetz JS, Cassano AD, Stoner MC, Ivatury RR, Levy MM. Feasibility
of endovascular repair in penetrating axillosubclavian injuries: a retro-
spective review. J Vasc Surg 2005;41:246-54.
17. DuBose JJ, Rajani R, Gilani R, Arthurs ZA, Morrison JJ, Clouse WD,
et al. Endovascular management of axillo-subclavian arterial injury: a
review of published experience. Injury 2012;43:1785-92.
18. Rubin DB, Thomas N. Matching using estimated propensity scores:
relating theory to practice. Biometrics 1996;52:249-64.
19. D’Agostino RB Jr. Propensity score methods for bias reduction in the
comparison of a treatment to a non-randomized control group. Stat
Med 1998;17:2265-81.
20. Karkos CD, Mair R, Markose G, Fishwick G, London NJ, Naylor AR.
Hybrid procedures combining open and endovascular surgical tech-
niques for the management of subclavian artery injuries. J Trauma
2007;63:E107-10.
21. Becker GJ, Benenati JF, Zemel G, Sallee DS, Suarez CA, Roeren TK,
et al. Percutaneous placement of a balloon-expandable intraluminal
graft for life-threatening subclavian arterial hemorrhage. J Vasc Interv
Radiol 1991;2:225-9.
22. Volodos NL, Karpovich IP, Troyan VI, Kalashnikova Y, Shekhanin VE,
Ternyuk NE, et al. Clinical experience of the use of self-ﬁxing synthetic
prostheses for remote endoprosthetics of the thoracic and the
abdominal aorta and iliac arteries through the femoral artery and as
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 5 Branco et al 1307intraoperative endoprosthesis for aorta reconstruction. Vasa Suppl
1991;33:93-5.
23. Reuben BC, Whitten MG, Sarfati M, Kraiss LW. Increasing use of
endovascular therapy in acute arterial injuries: analysis of the national
trauma data bank. J Vasc Surg 2007;46:1222-6.
24. Avery LE, Stahlfeld KR, Corcos AC, Scifres AM, Ziembicki JA,
Varcelotti J, et al. Evolving role of endovascular techniques for trau-
matic vascular injury: a changing landscape? J Trauma Acute Care Surg
2012;72:41-6; discussion: 46-7.
25. Kato N, Dake MD, Miller DC, Semba CP, Mitchell RS, Razavi MK,
et al. Traumatic thoracic aortic aneurysm: treatment with endovascular
stent-grafts. Radiology 1997;205:657-62.
26. Demetriades D, Velmahos GC, Scalea TM, Jurkovich GJ, Karmy-
Jones R, Teixeira PG, et al. Operative repair or endovascular stent graftin blunt traumatic thoracic aortic injuries: results of an American As-
sociation for the Surgery of Trauma multicenter study. J Trauma
2008;64:561-70; discussion: 570-1.
27. Khoynezhad A, Azizzadeh A, Donayre CE, Matsumoto A,
Velazquez O, White R, et al. Results of a multicenter, prospective trial
of thoracic endovascular aortic repair for blunt thoracic aortic injury
(RESCUE trial). J Vasc Surg 2013;57:899-905.e1.Submitted Mar 13, 2014; accepted May 5, 2014.
Additional material for this article may be found online
at www.jvascsurg.org.
Supplementary Table (online only). International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation
(ICD-9-CM) codes
Diagnosis Procedures
Head and neck
900
900.01 Common carotid artery Endovascular repair of
vessel 00.55, 00.61-5,
39.50, 39.7, 39.90
00.55 Insertion of drug-eluting peripheral
vascular stents, endografts, endovascular
grafts, or stent grafts
900.02 External carotid artery 00.61 Percutaneous angioplasty or atherectomy
of precerebral (extracranial) vessel(s)
900.03 Internal carotid artery 00.62 Percutaneous angioplasty or atherectomy
of intracranial vessel(s)
00.63 Percutaneous insertion of carotid artery
stents
00.64 Percutaneous insertion of other precerebral
(extracranial) artery stent(s)
00.65 Percutaneous insertion of intracranial
vascular stents
39.50 Angioplasty or atherectomy of other
noncoronary vessel(s)
39.71 Endovascular implantation of graft in
abdominal aorta
39.72 Endovascular repair or occlusion of head
and neck vessels
39.73 Endovascular implantation of graft in
thoracic aorta
39.74 Endovascular removal of obstruction from
head and neck vessels
39.79 Other endovascular repair of other vessels
39.90 Insertion of non-drug-eluting stent,
peripheral vessel
Thorax 901 901.0 Thoracic aorta Open repair of vessel 38.00-
38, 38.40-48, 38.60-68,
39.00-59
901.1 Innominate and subclavian
arteries
901.41 Pulmonary artery
Abdomen and
pelvis 902
902.0 Abdominal aorta
902.2 Celiac and mesenteric
arteries
902.41 Renal artery
902.51 Internal iliac artery
902.53 Common and external iliac
arteries
Upper
extremity
903
903.01 Axillary artery
903.1 Brachial artery
Lower
extremity
904
904.0 Common femoral artery
904.1 Superﬁcial femoral artery
904.41 Popliteal artery
904.51 Anterior tibial artery
904.53 Posterior tibial artery
Open repair of vessel excluded ICD-9-CM codes 39.27, arteriovenotomy for renal dialysis, and 38.5, ligation and stripping of varicose veins.
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